Anthropic and OpenEvidence target underserved health systems

Key Points

1. Anthropic and OpenEvidence will offer free AI clinical support to professionals in about 100 low- and middle-income countries.
2. The platform will adapt research-based answers to regional diseases, diagnostics, treatments and healthcare constraints.
3. The initiative could widen point-of-care access where medical journals, specialists and continuing education remain limited.

The latest

A specialized version of OpenEvidence will be provided free to healthcare professionals in about 100 low- and middle-income countries, including Uganda, Angola, Sudan, Haiti and Mongolia. Under the initiative announced Tuesday, Anthropic will supply the underlying artificial intelligence technology, while OpenEvidence will tailor the clinical decision-support platform to regional healthcare conditions, addressing differences in disease patterns, diagnostic resources, available treatments, infrastructure and access to specialists.

Details

• How it works: Doctors can submit clinical questions and receive answers grounded in peer-reviewed medical research and treatment guidelines. OpenEvidence is already free for clinicians in the United States and Europe, while the expansion is intended for settings with narrower access to journals, specialist expertise and continuing medical education.
• Local adaptation: OpenEvidence founder Daniel Nadler said everything being developed for participating countries would be context adaptive, adding that access to medical knowledge should not depend on geography. The company previously said it was working with health organizations in Rwanda and Botswana to account for local disease patterns, diagnostic resources and treatment options.
• Usage scale: Nadler said clinicians in the United States consulted OpenEvidence 42 million times in August alone. He estimated that several hundred million Americans will be treated during 2026 by doctors who use the platform to help guide care.
• Clinician perspective: Dr. Ahmed Bendary, a cardiologist at Benha University in Egypt, said expansion beyond the United States and Europe could be particularly significant in regions where access to major medical journals is restricted. The platform could deliver evidence-based information without requiring the institutional resources available at leading hospitals.
• Mobile distribution: Smartphones could provide a route to medical knowledge even in healthcare facilities without reliable round-the-clock electricity, Nadler said. That distribution channel could bring research and treatment guidance closer to the point of care in locations where physicians have limited access to major medical institutions.
• Anthropic’s expansion: The collaboration extends Anthropic’s push into high-impact scientific and healthcare applications. The company has also established a physical biology laboratory as it expands into drug science. Anthropic president Daniela Amodei said the technology had advanced enough for the deployment, but commercial incentives alone would not bring such tools to low-resource regions without entrepreneurial, philanthropically minded work. Financial terms were not disclosed.

Background

Medical AI can help clinicians navigate large volumes of research, but systems trained predominantly on high-income-country data may be difficult to apply elsewhere. Biases in datasets and guidelines can become consequential when local disease prevalence, diagnostic capabilities, treatment availability and healthcare infrastructure differ substantially.

What’s next

The initiative’s next indicator will be the rollout of the adapted platform across targeted countries and whether its guidance reflects locally available diagnostics, treatments, disease patterns and specialist resources.